#Diabetespal how to
#Diabetespal trial

The application also provides key information on diabetes medication.SmartView MD is a consolidated web based portal for medical providers to review (monitor and receive automated alerts of) patient vitals shared (via patient smartphones) from disparate selected 3rd party medical devices (e.g. The patient can set his mobile app to remind him daily to test his blood sugar level and to enter the readings into his smartphone. They can quickly intervene and modify his treatment plan, or communicate with him over the phone, between his clinic visits. The administration function of the mobile web app enables doctors and healthcare staff to remotely monitor the patientвЂ™s progress and hypoglycaemic episodes. The app also automatically generates graphs from the daily readings, so patients can easily see their progress in managing their diabetes. For instance, if the reading shows the patientвЂ™s blood sugar is low, the app will immediately alert him to lower or stop the insulin dosage. SGH Diabetes Pal features a dynamic guide that prompts the patient on what to do based on data on his changing real-time condition. Based on the data entered and the patientsвЂ™ prescribed treatment plan, the app will prompt them on the dosage of the insulin injection they need to administer to achieve optimum blood sugar levels. Patients using the SGH Diabetes Pal simply need to test their blood sugar level every morning before breakfast and input the reading into the mobile app.

#Diabetespal how to

This study will guide us on how to further employ mobile technologies to transform healthcare where there is partnership between the patient and doctor in managing the patientвЂ™s health.вЂќ About SGH Diabetes Pal IHiS and the public hospitals have developed several clinical mobile apps as part of our efforts to reach out beyond the hospital walls, to care for the elderly with chronic diseases in the community. On the decision to leverage on mobile apps, Dr Chong Yoke Sin, Chief Executive Officer, IHiS said: вЂњIn Singapore, there is high smartphone penetration among the general population, and increasingly among the elderly. The need to improve diabetes management deserves greater attention in Singapore where incidence is among the highest in developed countries, and diabetes prevalence is consistently high across ethnic groups,вЂќ said Professor David Matchar, Director for Health Services and Systems Research, Duke-NUS Graduate Medical School. вЂњDespite continuing research efforts towards improving healthcare delivery and disease outcomes for patients with diabetes, research gaps in diabetes management remain, particularly in the Asian setting. At the end of the study, the change in glycaemic control between both groups will be compared. They will be divided into two groups and receive individual counselling on all aspects of insulin treatment but only one group will be given access to the SGH Diabetes Pal.

#Diabetespal trial

вЂњThis study can potentially change current practices and improve the clinical understanding of diabetes management given the pervasiveness and simplicity of mobile apps,вЂќ said Dr Bee, who is also the site-Principal Investigator of the study.ДЄ total of 80 patients who are new to insulin therapy will be recruited for the randomised controlled trial and be put on the 24-week study. The SGH Diabetes Pal is an example of how we leverage on technology to achieve that goal,вЂќ said Dr Bee Yong Mong, Director, Diabetes Centre and Consultant, Department of Endocrinology, SGH. вЂњAs part of the Academic Healthcare Cluster, we are always looking at innovative ways to improve patient empowerment and clinical outcomes. This is the first such clinical trial involving mobile apps in a hospital setting. To study if the app can help patients achieve good glycaemic control, SGH and Duke-NUS Graduate Medical School are conducting a study to determine its effectiveness. This app takes the guesswork out of insulin injections by informing users of the required dosage based on the fasting blood sugar reading they input into the app every morning. Delayed dosage adjustment may result in the persistence of high sugar levels that could lead to serious diabetic complications.Дoctors from the Singapore General Hospital (SGH) Department of Endocrinology and Integrated Health Information Systems (IHiS) have developed a mobile application named вЂњSGH Diabetes PalвЂќ to help patients overcome the problem. Part of the reason is the lack of confidence to self-adjust insulin dosage without doctorвЂ™s supervision. Many patients with type 2 diabetes who are new to insulin therapy face the daily challenge of not knowing how much insulin to inject at the appropriate time.